Published in Diabetologia on January 18, 2007
The genetic contribution to non-syndromic human obesity. Nat Rev Genet (2009) 2.70
Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study. J Hypertens (2009) 1.61
Candidate molecular pathway genes related to appetite regulatory neural network, adipocyte homeostasis and obesity: results from the CARDIA Study. Ann Hum Genet (2010) 0.88
Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity (Silver Spring) (2011) 0.87
Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo. J Clin Endocrinol Metab (2009) 0.84
Meta-analyses between 18 candidate genetic markers and overweight/obesity. Diagn Pathol (2014) 0.80
Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs. J Hypertens (2013) 0.76
Lack of Association Between Variants within the AHSG , HCRT and NPY2R Genes and Anthropometrical Parameters in Czech Post-Monica Study. Balkan J Med Genet (2013) 0.75
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 14.15
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature (1991) 6.17
Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (1998) 5.75
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Genetic associations with human longevity at the APOE and ACE loci. Nat Genet (1994) 4.17
A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet (1998) 4.13
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet (1993) 2.56
Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia (2007) 2.48
Effect of iron supplementation on the iron status of pregnant women: consequences for newborns. Am J Clin Nutr (1997) 2.44
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet (1998) 2.44
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23
A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet (2001) 2.17
Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet (1996) 2.09
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet (1992) 1.95
Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest (1999) 1.89
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86
Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab (1997) 1.76
BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update (2012) 1.75
Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr (2001) 1.74
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Serum beta-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am J Clin Nutr (1997) 1.68
The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet (2000) 1.65
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes (1996) 1.60
Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab (2000) 1.59
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia (2000) 1.57
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest (1993) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Functional gastrointestinal disorders in 35,447 adults and their association with body mass index. Aliment Pharmacol Ther (2015) 1.53
A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia (2007) 1.50
Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet (1997) 1.48
Workplace air-conditioning and health services attendance among French middle-aged women: a prospective cohort study. Int J Epidemiol (2004) 1.47
Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia (1998) 1.46
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia (2005) 1.44
A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet (1997) 1.44
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr (2005) 1.44
Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children. Diabetologia (1989) 1.41
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A (1993) 1.40
Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci U S A (1992) 1.40
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
Iodine deficiency in France. Lancet (1999) 1.39
Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab (2012) 1.36
Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr (1996) 1.32
Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ (1997) 1.32
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31
Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. Int J Obes (Lond) (2009) 1.30
HNF1alpha controls renal glucose reabsorption in mouse and man. EMBO Rep (2000) 1.29
Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem (2001) 1.28
Biological markers of alcohol intake among 4796 subjects injured in accidents. Br Med J (Clin Res Ed) (1986) 1.28
Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing. Biotechniques (2002) 1.27
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab (2000) 1.26
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord (2000) 1.26
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes (2001) 1.25
Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial. Eur J Clin Nutr (2006) 1.25
Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab (1998) 1.24
Evaluation of microcomputer nutritional teaching games in 1,876 children at school. Diabetes Metab (2001) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology (1996) 1.23
Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians. Diabetologia (2003) 1.21
Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis (2000) 1.20
Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity. Diabetes Metab (2004) 1.20
Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc (2000) 1.20
Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Nutr Metab Cardiovasc Dis (2012) 1.19
A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet (1995) 1.18
Replication of 13 obesity loci among Singaporean Chinese, Malay and Asian-Indian populations. Int J Obes (Lond) (2011) 1.17
Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev (2011) 1.16
Nutritional anaemias. Baillieres Clin Haematol (1992) 1.15
Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond) (2006) 1.15
Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord (2002) 1.15
European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab (2012) 1.14
Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. Ophthalmology (1999) 1.14
Human genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease. Cytogenet Genome Res (2009) 1.13
Impact of musculoskeletal disorders on quality of life: an inception cohort study. Ann Rheum Dis (2004) 1.13
Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia (1996) 1.12
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.11
Indication for linkage of the human OB gene region with extreme obesity. Diabetes (1996) 1.10
No evidence for a major beta-cell dysfunction in young adults born with intra-uterine growth retardation. Pediatr Diabetes (2000) 1.10
Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol (1998) 1.10
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab (1997) 1.10
Diet quality and dietary diversity in France: implications for the French paradox. J Am Diet Assoc (1996) 1.10
Non-sense mutation of glucokinase gene. Lancet (1993) 1.09